Remove FDA Remove Independent Pharmacies Remove Medical Records
article thumbnail

Tirzepatide, Hormone Therapy Combination Increases Weight Loss Among Postmenopausal Women

Drug Topics

Data for the study was gathered from electronic medical records. A team of investigators from the Division of Endocrinology at the Mayo Clinic conducted a real-world study to determine if concurrent menopause hormone therapy enhances the effectiveness of tirzepatide for weight loss in postmenopausal women.

article thumbnail

How to get insurance to cover Ozempic for weight loss

The Checkup by Singlecare

Ozempic (semaglutide) is a brand-name injectable prescription medication administered once weekly. It’s in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, approved by the Food and Drug Administration (FDA) to manage blood sugar levels in adults with Type 2 diabetes when combined with diet and exercise.